In women with concurrent obesity, obstructive sleep apnea (OSA), and endometrial cancer, adipokines (leptin/adiponectin) and estrogen pathways collectively regulate metabolic dysfunction (12–14). The gene discussed is LEP; the disease is obstructive sleep apnea syndrome.